End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,010 KRW | +0.17% | -2.91% | -33.59% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Product Sales (ODM)
64.8
%
| - | - | 210 | 64.8 % | - |
Product Sales (General)
19.1
%
| - | - | 62 | 19.1 % | - |
Reagent
16.2
%
| 48 | 100.0 % | 52 | 16.2 % | +8.19% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 48 | 100.0 % | 324 | 100.0 % | +569.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Su-Jin Lee
FOU | Founder | 55 | 09-07-23 |
Sung-Hwan Moon
PSD | President | 65 | - |
Jun-Hee Jung
DFI | Director of Finance/CFO | 54 | - |
Jung-Ho Park
AUD | Comptroller/Controller/Auditor | 53 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Su-Jin Lee
FOU | Founder | 55 | 09-07-23 |
Jong-Nam Suh
BRD | Director/Board Member | 62 | - |
Sung-Hwan Moon
PSD | President | 65 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,298,866 | 14,602,673 ( 65.49 %) | 0 | 65.49 % |
Stock B | 0 | 1,037,574 | 0 | 0 |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-33.59% | 97.85M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- A293780 Stock
- Company AptaBio Therapeutics Inc.